A Cautionary Tale about Supplemental Oxygen: The Albatross of Neonatal Medicine

Pediatrics

Volumn 113, Issue 2, 2004, Pages 394-396

  Silverman, William A ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIAL OXYGEN TENSION; BLINDNESS; BRAIN INJURY; CHRONIC LUNG DISEASE; HISTORY OF MEDICINE; HUMAN; MORTALITY; NEWBORN; NEWBORN CARE; OXYGEN THERAPY; PREMATURITY; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; REVIEW; RISK BENEFIT ANALYSIS;

HISTORY, 18TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; OXYGEN; OXYGEN INHALATION THERAPY; RANDOMIZED CONTROLLED TRIALS; RETINOPATHY OF PREMATURITY;

EID: 0842303411     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.113.2.394     Document Type: Review

References (18)

1. Huxley TH. A liberal education. In Bibby C. The Essence of T. H. Huxley London, United Kingdom: Macmillan; 1967
2. Priestly J. Experiments and Observations on Different Kinds of Air. Quoted by Gilbert Martin. Available at: http://www.mtsinai.org/pulmonary/papers/ox-hist/ox-hist1.html. Accessed August 22, 2003
3. Silverman WA. Negative discovery. Paediatr Perinat Epidemiol. 2002;16:192-193
4. Saugstad OD. Oxygen supplementation in the newborn period: Do we know the consequences? Yearbook of Neonatal and Perinatal Medicine. 2002:xv-xxii
5. Wilson JL, Long SB, Howard PJ. Respiration of premature infants; response to variations of oxygen and to increased carbon dioxide in inspired air. Am J Dis Child. 1942;63:1080-1085
6. Smith CA, Kaplan E. Adjustment of blood oxygen levels in neonatal life. Am J Dis Child. 1942;64:843-859
7. Silverman WA. Retrolental Fibroplasia: A Modern Parable. New York, NY: Grune & Stratton, Inc; 1980. Available at: http://neonatology.org/classics/parable/default.html. Accessed August 6, 2002
8. Crosse VM. The problem of retrolental fibroplasia in the City of Birmingham. Trans Ophthalmol Soc U K. 1951;71:609-612
9. Campbell K. Intensive oxygen therapy as a possible cause of retrolental fibroplasia: a clinical approach. Med J Aust. 1951;2:48-50
10. Kinsey VE. Etiology of retrolental fibroplasia and preliminary report of the Cooperative Study of Retrolental Fibroplasia. Trans Am Acad Ophthalmol Otolaryngol. 1955;59:15-24
11. Bolton DPG, Cross KW. Further observations on the cost of preventing retrolental fibroplasia. Lancet. 1974;1:445-448
12. 2 levels and retrolental fibroplasia: a report of the cooperative study. Pediatrics. 1977;60:655-668
13. The STOP-ROP Multicenter Study Group. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. 1: primary outcomes. Pediatrics. 2000;105:295-310
14. Tin W, Milligan WA, Pennefather P, Hey E. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonatal Ed. 2001;84:F106-F110
15. Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med. 2003;349:959-967
16. Sjöstedt S, Rooth G. Low oxygen tension in the management of newborn infants. Arch Dis Child. 1957;32:397-400
17. Tin W. Oxygen therapy: 50 years of uncertainty. Pediatrics. 2002;110:615-616
18. Cole CH, Wright KW, Phelps DL. Resolving our uncertainty about oxygen therapy. Pediatrics. 2003;112:1415-1419